PH22955A - Process for the preparation of aromatic 1,4-oxazepinones and intermediates thereof - Google Patents
Process for the preparation of aromatic 1,4-oxazepinones and intermediates thereofInfo
- Publication number
- PH22955A PH22955A PH32802A PH32802A PH22955A PH 22955 A PH22955 A PH 22955A PH 32802 A PH32802 A PH 32802A PH 32802 A PH32802 A PH 32802A PH 22955 A PH22955 A PH 22955A
- Authority
- PH
- Philippines
- Prior art keywords
- oxazepinones
- intermediates
- aromatic
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/652,017 US4610819A (en) | 1984-09-19 | 1984-09-19 | Process for the preparation of aromatic-1,4-oxazepinones and thiones |
Publications (1)
Publication Number | Publication Date |
---|---|
PH22955A true PH22955A (en) | 1989-02-03 |
Family
ID=24615185
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH32802A PH22955A (en) | 1984-09-19 | 1985-09-18 | Process for the preparation of aromatic 1,4-oxazepinones and intermediates thereof |
PH34640A PH23204A (en) | 1984-09-19 | 1986-12-22 | Process for the preparation of aromtic-1,4-oxazepinones and thiones |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH34640A PH23204A (en) | 1984-09-19 | 1986-12-22 | Process for the preparation of aromtic-1,4-oxazepinones and thiones |
Country Status (20)
Country | Link |
---|---|
US (1) | US4610819A (es) |
EP (1) | EP0175570A3 (es) |
JP (1) | JPS6178789A (es) |
KR (1) | KR900003852B1 (es) |
AU (2) | AU586440B2 (es) |
CA (1) | CA1277983C (es) |
DK (1) | DK423485A (es) |
ES (1) | ES8802305A1 (es) |
FI (1) | FI853585L (es) |
GR (1) | GR852247B (es) |
HU (2) | HU194245B (es) |
IL (1) | IL76243A (es) |
IN (1) | IN162290B (es) |
NO (1) | NO853665L (es) |
NZ (1) | NZ213523A (es) |
PH (2) | PH22955A (es) |
PL (2) | PL147855B1 (es) |
PT (1) | PT81157B (es) |
YU (2) | YU142785A (es) |
ZA (1) | ZA856527B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4746655A (en) * | 1987-06-10 | 1988-05-24 | A. H. Robins Company, Incorporated | Fused aromatic-spiropiperidine oxazepinones(and thiones) |
GB8727385D0 (en) * | 1987-11-23 | 1987-12-23 | Lundbeck & Co As H | Heterocyclic compounds |
WO2019173761A1 (en) | 2018-03-09 | 2019-09-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3794639A (en) * | 1966-03-10 | 1974-02-26 | Squibb & Sons Inc | Benzoxazepines and benzothiazepines |
ZA836994B (en) * | 1982-09-30 | 1984-05-30 | Robins Co Inc A H | Fused aromatic oxazepinones and sulfur analogs thereof |
EP0107930B1 (en) * | 1982-09-30 | 1990-11-28 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | Fused aromatic oxazepinones and sulphur analogues thereof and their preparation and use in counteracting histamine |
-
1984
- 1984-09-19 US US06/652,017 patent/US4610819A/en not_active Expired - Fee Related
-
1985
- 1985-08-27 ZA ZA856527A patent/ZA856527B/xx unknown
- 1985-08-28 IL IL76243A patent/IL76243A/xx unknown
- 1985-08-30 IN IN680/MAS/85A patent/IN162290B/en unknown
- 1985-09-11 YU YU01427/85A patent/YU142785A/xx unknown
- 1985-09-16 GR GR852247A patent/GR852247B/el unknown
- 1985-09-17 EP EP85306604A patent/EP0175570A3/en not_active Withdrawn
- 1985-09-18 PL PL1985255423A patent/PL147855B1/pl unknown
- 1985-09-18 PT PT81157A patent/PT81157B/pt not_active IP Right Cessation
- 1985-09-18 CA CA000491001A patent/CA1277983C/en not_active Expired - Fee Related
- 1985-09-18 ES ES547084A patent/ES8802305A1/es not_active Expired
- 1985-09-18 PH PH32802A patent/PH22955A/en unknown
- 1985-09-18 NZ NZ213523A patent/NZ213523A/xx unknown
- 1985-09-18 DK DK423485A patent/DK423485A/da not_active Application Discontinuation
- 1985-09-18 PL PL1985275622A patent/PL150760B1/pl unknown
- 1985-09-18 KR KR1019850006808A patent/KR900003852B1/ko not_active IP Right Cessation
- 1985-09-18 FI FI853585A patent/FI853585L/fi not_active Application Discontinuation
- 1985-09-18 HU HU853517A patent/HU194245B/hu unknown
- 1985-09-18 NO NO853665A patent/NO853665L/no unknown
- 1985-09-18 HU HU864472A patent/HU195485B/hu unknown
- 1985-09-19 AU AU47673/85A patent/AU586440B2/en not_active Ceased
- 1985-09-19 JP JP60207713A patent/JPS6178789A/ja active Pending
-
1986
- 1986-12-22 PH PH34640A patent/PH23204A/en unknown
-
1987
- 1987-07-31 YU YU01441/87A patent/YU144187A/xx unknown
-
1989
- 1989-08-18 AU AU40047/89A patent/AU4004789A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PH23204A (en) | 1989-06-06 |
YU144187A (en) | 1988-10-31 |
JPS6178789A (ja) | 1986-04-22 |
FI853585A0 (fi) | 1985-09-18 |
HUT42070A (en) | 1987-06-29 |
ES547084A0 (es) | 1987-03-16 |
IL76243A (en) | 1990-07-26 |
NZ213523A (en) | 1989-08-29 |
EP0175570A2 (en) | 1986-03-26 |
AU4767385A (en) | 1986-03-27 |
KR860002484A (ko) | 1986-04-26 |
CA1277983C (en) | 1990-12-18 |
EP0175570A3 (en) | 1988-07-20 |
AU586440B2 (en) | 1989-07-13 |
PT81157B (pt) | 1987-10-20 |
HU195485B (en) | 1988-05-30 |
GR852247B (es) | 1986-01-17 |
AU4004789A (en) | 1989-12-07 |
PL255423A1 (en) | 1987-05-18 |
US4610819A (en) | 1986-09-09 |
PL150760B1 (en) | 1990-06-30 |
PT81157A (en) | 1985-10-01 |
DK423485A (da) | 1986-03-20 |
FI853585L (fi) | 1986-03-20 |
ZA856527B (en) | 1986-04-30 |
IN162290B (es) | 1988-04-23 |
ES8802305A1 (es) | 1987-03-16 |
HU194245B (en) | 1988-01-28 |
DK423485D0 (da) | 1985-09-18 |
HUT40426A (en) | 1986-12-28 |
PL147855B1 (en) | 1989-08-31 |
NO853665L (no) | 1986-03-20 |
IL76243A0 (en) | 1986-01-31 |
YU142785A (en) | 1988-02-29 |
KR900003852B1 (ko) | 1990-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0313061A3 (en) | Improved process for the manufacture of 1,1,1-trifluorodichloroethane and 1,1,1,2-tetrafluorochloroethane | |
IL71274A0 (en) | Process and intermediates for the preparation of 1alpha,25-dihydroxyergocalciferol | |
HU900191D0 (en) | Process for preparation of 1,1,1-trifluor-2-aryl-propane-3-ols | |
DE3662256D1 (en) | Process for the preparation of (2,2)-paracyclophane | |
DE3569375D1 (en) | Process for the preparation of 1,2-benzisothiazolones | |
PL266932A1 (en) | The method of manufacture of new 1,4-benzodiasepine | |
PT81526A (en) | Process for the preparation of new homopropargylamines | |
DE3567638D1 (en) | 2,4-dichloro-3-alkyl-6-nitrophenols and process for their preparation | |
DE3561054D1 (en) | Process for the preparation of 2,4-dichloro-5-fluoro-benzoic acid | |
IL80305A (en) | Process for the preparation of ypsilon-butyrolactams and some novel intermediates | |
EP0206147A3 (en) | Process for the preparation of 4,4'-dinitrodibenzyls | |
IL77661A (en) | Process for the preparation of 4,4-azetidinones,and novel intermediates thereof | |
DE3568327D1 (en) | Process for the preparation of 2,3,5-trimethylbenzoquinone | |
PH22955A (en) | Process for the preparation of aromatic 1,4-oxazepinones and intermediates thereof | |
PT83799A (en) | Process for the preparation of novel 2,2:-bi-1h-imidazoles | |
ZA85591B (en) | Process and intermediates for the preparation of aryl substituted pyrido(1,4)benzodiazepines | |
PT85023A (en) | Process for the preparation of substituted 2-phenylacetil-1,3,5-cyclohexanetriones and of intermediates | |
DE3562237D1 (en) | Process for the preparation of 1,4-diamino-2,3-dicyanoanthraquinone | |
EP0198795A3 (en) | Process for the preparation of 1,4-diaminoanthraquinones | |
DE3560747D1 (en) | Substituted 2-(1-amino-akylidenyl)1,3-indane diones, process for their preparation and their therapeutical use | |
PT83637A (en) | Process for the preparation of antidepressant 5-heterocyclic-2,4-dialkyl-3h-1,2,4-triazole-3-thiones | |
EP0206293A3 (en) | Process for the preparation of 3,5-dichloro-2-pyridone | |
GB2165242B (en) | Process for the preparation of 1, 2-benzoxathiine derivatives | |
DE3662784D1 (en) | Process for the preparation of 1,3,6,8-tetrabromopyrene | |
EP0161548A3 (en) | Process for the preparation of riboflavin, and intermediates for this process |